One downside to the U.S.’s lackluster genome sequencing is that the true number of Covid-19 reinfections remains unknown. Here’s why that matters.
One downside to the U.S.’s lackluster genome sequencing is that the true number of Covid-19 reinfections remains unknown. Here’s why that matters.